112 related articles for article (PubMed ID: 38147761)
1. Eukaryotic Translation Initiation Factor 2 Subunit β as a Prognostic Biomarker Associates With Immune Cell Infiltration in Breast Cancer.
Guo M; Ying Y; Chen Y; Miao X; Cui H; Yu Z; Wang X
J Surg Res; 2024 Mar; 295():753-762. PubMed ID: 38147761
[TBL] [Abstract][Full Text] [Related]
2. EIF2S2 is a novel independent prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Liu J; Liu T; Zhang C; He J; Zhou D; Wang Z; Wang R
Front Genet; 2022; 13():992343. PubMed ID: 36276981
[No Abstract] [Full Text] [Related]
3. EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma.
Cao Z; Jing Y; Cheng C; Wang F; Guan M; Zhang K; Jiao J; Ruan L; Chen Z
Front Biosci (Landmark Ed); 2024 Mar; 29(3):119. PubMed ID: 38538250
[TBL] [Abstract][Full Text] [Related]
4. Prognostic prediction and gene regulation network of
Ji P; Wang H; Cheng Y; Liang S
J Gastrointest Oncol; 2021 Dec; 12(6):3061-3078. PubMed ID: 35070430
[TBL] [Abstract][Full Text] [Related]
5. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
6. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
[TBL] [Abstract][Full Text] [Related]
7. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
8. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
9. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
Liang H; Zhou G; Lv L; Lu J; Peng J
Breast Cancer; 2021 Mar; 28(2):379-386. PubMed ID: 33067762
[TBL] [Abstract][Full Text] [Related]
10. RBP EIF2S2 Promotes Tumorigenesis and Progression by Regulating MYC-Mediated Inhibition via FHIT-Related Enhancers.
Zhang J; Li S; Zhang L; Xu J; Song M; Shao T; Huang Z; Li Y
Mol Ther; 2020 Apr; 28(4):1105-1118. PubMed ID: 32059763
[TBL] [Abstract][Full Text] [Related]
11. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
12. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
[TBL] [Abstract][Full Text] [Related]
13. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
15. Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer.
Liu M; Li Q; Zhao N
Bioengineered; 2021 Dec; 12(1):8419-8434. PubMed ID: 34661511
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
[TBL] [Abstract][Full Text] [Related]
18. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
[TBL] [Abstract][Full Text] [Related]
19. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
[TBL] [Abstract][Full Text] [Related]
20. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
